2026年5月4日
Official Listing: Recombinant Collagen Gynecological Gel on Guizhou Procurement Platform
Good News! Our Medical Recombinant Collagen Gynecological Gel Successfully Listed on Guizhou Medical Consumables Procurement Platform
Recently, the Medical Recombinant Collagen Gynecological Gel under Wuhan Heyuan Biotechnology Co., Ltd. has successfully completed the listing procedure on the Drug and Medical Consumables Procurement Management System of Guizhou Province, and been officially included in the Guizhou Medical Consumables Procurement Platform, marking a key step forward in the commercialization process of the product!
About the Listed Product
The Medical Recombinant Collagen Gynecological Gel successfully listed this time is a Class II medical device independently developed by our company, which has obtained the medical device registration certificate issued by Hubei Provincial Medical Products Administration (Registration Certificate No.: E Medical Device Approval 20252185862).
The product forms a protective gel membrane on the vaginal wall to physically isolate external pathogenic microorganisms, providing compliant protection solutions for women’s private health. The full range of specifications is covered in this listing.
Significance of Successful Listing
The listing of medical consumables is a core access step for products to enter the procurement system of medical institutions, as well as a key prerequisite for market implementation. The successful listing is a milestone for the company:
- Breakthrough in Channel Access: The product has officially obtained the procurement qualification of medical institutions in Guizhou Province, paving the way for subsequent entry into hospitals at all levels and primary medical institutions, and greatly expanding market coverage.
- Proof of Market Recognition: The successful listing represents the authoritative recognition of the product’s quality, compliance and market value by regulatory authorities and procurement platforms, providing strong support for product promotion.
- Accelerated Commercialization: This listing is a key step from R&D, registration to market implementation, marking that the company’s products have officially entered the market-oriented operation stage and laying a solid foundation for subsequent sales growth and brand building.
Future Outlook
The successful listing is an important milestone in the commercialization process of women’s health products of Wuhan Heyuan Biotechnology Co., Ltd. In the future, the company will take this opportunity to continuously promote the listing application of products in other provinces across the country, and constantly improve product quality and service capabilities, so as to provide compliant and high-quality health products and solutions for more medical institutions and users, and boost the development of women’s health cause.
Wuhan Heyuan Biotechnology Co., Ltd.
April 20, 2026